SciBase Uppsala is a manufacturer specializing in advanced medical technology, particularly in the field of skin cancer diagnostics. The company focuses on developing innovative solutions that enhance the accuracy of skin cancer detection, utilizing electrical impedance spectroscopy. This technology allows for non-invasive assessment of skin lesions, providing healthcare professionals with valuable tools for early diagnosis.
Founded in 2005, SciBase has established itself as a key player in the dermatology sector, working closely with medical professionals to improve patient outcomes. The company's flagship product, Nevisense, is designed to assist in the evaluation of suspicious moles and lesions, aiming to reduce unnecessary biopsies and improve the efficiency of skin cancer screening processes. SciBase's commitment to research and development ensures that it remains at the forefront of technological advancements in skin health diagnostics.